• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

RGN-259(胸腺肽 β4)在干眼症模型中与处方药物相比,具有改善临床上重要的干眼症疗效的作用。

RGN-259 (thymosin β4) improves clinically important dry eye efficacies in comparison with prescription drugs in a dry eye model.

机构信息

Department of Ophthalmology, Inje University College of Medicine, Inje University Busan Paik Hospital, Busan, 47392, Korea.

Department of Biochemistry and Molecular Biology, The George Washington University School of Medicine, Washington D.C, USA.

出版信息

Sci Rep. 2018 Jul 12;8(1):10500. doi: 10.1038/s41598-018-28861-5.

DOI:10.1038/s41598-018-28861-5
PMID:30002412
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC6043477/
Abstract

This study evaluated the clinical activity of RGN-259 (thymosin β4) in comparison with cyclosporine A (CsA), diquafosol (DQS), and lifitegrast (LFA) in a murine model of dry eye. The model was NOD.B10-H2 mice in a 30-40% humidified environment together with daily scopolamine hydrobromide injections for 10 days. After desiccation stress, all drugs were evaluated after 10 treatment days. RGN-259 increased tear production similar to that in the DQS- and LFA-treated mice while CsA was inactive. RGN-259 improved corneal smoothness and decreased fluorescein staining similar to that of LFA group while CsA and DQS were inactive. Corneal epithelial detachment was reduced by RGN-259, and DQS and LFA showed similar activity but the CsA was inactive. RGN-259 increased conjunctival goblet cells and mucin production comparable to that seen with CsA, while DQS and LFA were inactive. RGN-259 reduced the over-expression of inflammatory factors comparable to that with CsA and LFA, while DQS was inactive. RGN-259 increased mucin production comparable to that observed with CsA, while DQS and LFA were inactive. In conclusion, RGN-259 promoted recovery of mucins and goblet cells, improved corneal integrity, and reduced inflammation in a dry eye mouse model and was equal to or more effective than prescription treatments.

摘要

本研究评估了 RGN-259(胸腺肽 β4)在干眼症小鼠模型中与环孢素 A(CsA)、地夸磷索(DQS)和利福平(LFA)相比的临床疗效。该模型为 NOD.B10-H2 小鼠,在 30-40%湿度环境下,每天接受氢溴酸东莨菪碱注射 10 天。干燥应激后,所有药物在 10 天治疗后进行评估。RGN-259 增加泪液分泌的作用与 DQS 和 LFA 治疗的小鼠相似,而 CsA 则无作用。RGN-259 改善角膜平整度和减少荧光素染色的作用与 LFA 组相似,而 CsA 和 DQS 则无作用。RGN-259 减少了角膜上皮脱落,DQS 和 LFA 表现出相似的活性,但 CsA 无作用。RGN-259 增加结膜杯状细胞和粘蛋白产生的作用与 CsA 相似,而 DQS 和 LFA 则无作用。RGN-259 减少了炎症因子的过度表达,与 CsA 和 LFA 相似,而 DQS 则无作用。RGN-259 增加粘蛋白产生的作用与 CsA 相似,而 DQS 和 LFA 则无作用。总之,RGN-259 促进了粘蛋白和杯状细胞的恢复,改善了角膜完整性,减少了干眼症小鼠模型中的炎症,与处方治疗等效或更有效。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/11c7/6043477/4c9417147db4/41598_2018_28861_Fig8_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/11c7/6043477/08f483d588d1/41598_2018_28861_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/11c7/6043477/9045e31bdee2/41598_2018_28861_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/11c7/6043477/8e466d68daf9/41598_2018_28861_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/11c7/6043477/f91e78349bf4/41598_2018_28861_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/11c7/6043477/aa20d2c2b19c/41598_2018_28861_Fig5_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/11c7/6043477/617ffda6c5c5/41598_2018_28861_Fig6_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/11c7/6043477/7f5860317e12/41598_2018_28861_Fig7_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/11c7/6043477/4c9417147db4/41598_2018_28861_Fig8_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/11c7/6043477/08f483d588d1/41598_2018_28861_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/11c7/6043477/9045e31bdee2/41598_2018_28861_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/11c7/6043477/8e466d68daf9/41598_2018_28861_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/11c7/6043477/f91e78349bf4/41598_2018_28861_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/11c7/6043477/aa20d2c2b19c/41598_2018_28861_Fig5_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/11c7/6043477/617ffda6c5c5/41598_2018_28861_Fig6_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/11c7/6043477/7f5860317e12/41598_2018_28861_Fig7_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/11c7/6043477/4c9417147db4/41598_2018_28861_Fig8_HTML.jpg

相似文献

1
RGN-259 (thymosin β4) improves clinically important dry eye efficacies in comparison with prescription drugs in a dry eye model.RGN-259(胸腺肽 β4)在干眼症模型中与处方药物相比,具有改善临床上重要的干眼症疗效的作用。
Sci Rep. 2018 Jul 12;8(1):10500. doi: 10.1038/s41598-018-28861-5.
2
Cevimeline-induced anti-inflammatory effect through upregulations of mucins in the ocular surface of a dry eye mouse model.西维美林通过上调干眼模型小鼠眼表面黏蛋白发挥抗炎作用。
Biomed Pharmacother. 2021 Jul;139:111571. doi: 10.1016/j.biopha.2021.111571. Epub 2021 Apr 13.
3
Effects of eye drops containing a mixture of 3% diquafosol sodium and tocopherol acetate (vitamin E) on the ocular surface of murine dry eye.含有3%双醋瑞因钠和醋酸生育酚(维生素E)混合物的滴眼液对小鼠干眼眼表的影响。
Cutan Ocul Toxicol. 2021 Dec;40(4):350-358. doi: 10.1080/15569527.2021.1973022. Epub 2021 Sep 8.
4
Effects of silk fibroin in murine dry eye.丝素蛋白对小鼠干眼症的影响。
Sci Rep. 2017 Mar 10;7:44364. doi: 10.1038/srep44364.
5
Comparison of Ocular Surface Mucin Expression After Topical Ophthalmic Drug Administration in Dry Eye-Induced Mouse Model.眼局部用药对干眼诱导模型小鼠眼表黏蛋白表达的影响比较。
J Ocul Pharmacol Ther. 2018 Nov;34(9):612-620. doi: 10.1089/jop.2018.0005. Epub 2018 Oct 16.
6
Long-Term Topical Diquafosol Tetrasodium Treatment of Dry Eye Disease Caused by Chronic Graft-Versus-Host Disease: A Retrospective Study.长期局部应用四水二喹富乐定治疗慢性移植物抗宿主病所致干眼症:一项回顾性研究。
Eye Contact Lens. 2018 Nov;44 Suppl 2:S215-S220. doi: 10.1097/ICL.0000000000000455.
7
Changes in Human Tear Proteome Following Topical Treatment of Dry Eye Disease: Cyclosporine A Versus Diquafosol Tetrasodium.干眼症经局部治疗后的人泪液蛋白质组变化:环孢素 A 与地夸磷索钠。
Invest Ophthalmol Vis Sci. 2019 Dec 2;60(15):5035-5044. doi: 10.1167/iovs.19-27872.
8
Anti-inflammatory effect of hydroxyproline-GQDGLAGPK in desiccation stress-induced experimental dry eye mouse.羟脯氨酸-GQDGLAGPK 对干燥应激诱导的实验性干眼小鼠的抗炎作用。
Sci Rep. 2017 Aug 7;7(1):7413. doi: 10.1038/s41598-017-07965-4.
9
A New Ophthalmic Pharmaceutical Formulation, Topical Sulglycotide, Enhances the Ocular Mucin Secretion in Desiccation Stress-Mediated Dry Eye Disease.一种新的眼科药物制剂,局部苏糖赖氨酸,可增强干燥应激介导的干眼症中的眼粘液分泌。
Invest Ophthalmol Vis Sci. 2019 Mar 1;60(4):1076-1087. doi: 10.1167/iovs.18-24935.
10
Topical steroid and non-steroidal anti-inflammatory drugs inhibit inflammatory cytokine expression on the ocular surface in the botulinum toxin B-induced murine dry eye model.在肉毒杆菌毒素B诱导的小鼠干眼模型中,局部用类固醇和非甾体抗炎药可抑制眼表炎症细胞因子的表达。
Mol Vis. 2012;18:1803-12. Epub 2012 Jul 3.

引用本文的文献

1
Identification of glutamine as a potential therapeutic target in dry eye disease.确定谷氨酰胺作为干眼症的潜在治疗靶点。
Signal Transduct Target Ther. 2025 Jan 22;10(1):27. doi: 10.1038/s41392-024-02119-1.
2
Dry Eye Disease: An Update on Changing Perspectives on Causes, Diagnosis, and Management.干眼病:病因、诊断及治疗观念转变的最新进展
Cureus. 2024 May 9;16(5):e59985. doi: 10.7759/cureus.59985. eCollection 2024 May.
3
Ocular Surface Ion Transport and Dry Eye Disease.眼表离子转运与干眼疾病

本文引用的文献

1
Recapitulation of developmental mechanisms to revascularize the ischemic heart.发育机制概述:为缺血性心脏重新建立血供。
JCI Insight. 2017 Nov 16;2(22). doi: 10.1172/jci.insight.96800.
2
Anti-inflammatory effect of hydroxyproline-GQDGLAGPK in desiccation stress-induced experimental dry eye mouse.羟脯氨酸-GQDGLAGPK 对干燥应激诱导的实验性干眼小鼠的抗炎作用。
Sci Rep. 2017 Aug 7;7(1):7413. doi: 10.1038/s41598-017-07965-4.
3
TFOS DEWS II Definition and Classification Report.TFOS DEWS II 定义与分类报告。
Curr Ophthalmol Rep. 2022 Dec;10(4):188-197. doi: 10.1007/s40135-022-00295-3. Epub 2022 Oct 20.
4
Deficiency of endothelial sirtuin1 in mice stimulates skeletal muscle insulin sensitivity by modifying the secretome.内皮细胞沉默调节蛋白 1 缺乏症可通过改变分泌组来刺激小鼠骨骼肌胰岛素敏感性。
Nat Commun. 2023 Sep 11;14(1):5595. doi: 10.1038/s41467-023-41351-1.
5
Thymosin β4 Alleviates Autoimmune Dacryoadenitis via Suppressing Th17 Cell Response.胸腺素 β4 通过抑制 Th17 细胞应答缓解自身免疫性泪腺炎。
Invest Ophthalmol Vis Sci. 2023 Aug 1;64(11):3. doi: 10.1167/iovs.64.11.3.
6
Intricate insights into immune response in dry eye disease.深入了解干眼症中的免疫反应。
Indian J Ophthalmol. 2023 Apr;71(4):1248-1255. doi: 10.4103/IJO.IJO_481_23.
7
Management of Sjogren's Dry Eye Disease-Advances in Ocular Drug Delivery Offering a New Hope.干燥综合征干眼疾病的管理——眼部药物递送的进展带来新希望。
Pharmaceutics. 2022 Dec 31;15(1):147. doi: 10.3390/pharmaceutics15010147.
8
0.1% RGN-259 (Thymosin ß4) Ophthalmic Solution Promotes Healing and Improves Comfort in Neurotrophic Keratopathy Patients in a Randomized, Placebo-Controlled, Double-Masked Phase III Clinical Trial.0.1% RGN-259(胸腺素 β4)滴眼液在一项随机、安慰剂对照、双盲 III 期临床试验中促进神经营养性角膜病变患者的愈合并改善舒适度。
Int J Mol Sci. 2022 Dec 29;24(1):554. doi: 10.3390/ijms24010554.
9
Transgenic dry eye mouse models: powerful tools to study dry eye disease.转基因干眼小鼠模型:研究干眼病的有力工具。
Int J Ophthalmol. 2022 Apr 18;15(4):635-645. doi: 10.18240/ijo.2022.04.18. eCollection 2022.
10
Current Advances in Mechanisms and Treatment of Dry Eye Disease: Toward Anti-inflammatory and Immunomodulatory Therapy and Traditional Chinese Medicine.干眼症的发病机制与治疗新进展:抗炎和免疫调节治疗与传统中医
Front Med (Lausanne). 2022 Jan 17;8:815075. doi: 10.3389/fmed.2021.815075. eCollection 2021.
Ocul Surf. 2017 Jul;15(3):276-283. doi: 10.1016/j.jtos.2017.05.008. Epub 2017 Jul 20.
4
Therapeutic Efficacy of Nanocomplex of Poly(Ethylene Glycol) and Catechin for Dry Eye Disease in a Mouse Model.聚乙二醇与儿茶素纳米复合物对小鼠干眼症模型的治疗效果
Invest Ophthalmol Vis Sci. 2017 Mar 1;58(3):1682-1691. doi: 10.1167/iovs.16-20843.
5
Effects of silk fibroin in murine dry eye.丝素蛋白对小鼠干眼症的影响。
Sci Rep. 2017 Mar 10;7:44364. doi: 10.1038/srep44364.
6
LFA-1/ICAM-1 Interaction as a Therapeutic Target in Dry Eye Disease.LFA-1/ICAM-1 相互作用作为干眼病的治疗靶点。
J Ocul Pharmacol Ther. 2017 Jan/Feb;33(1):5-12. doi: 10.1089/jop.2016.0105. Epub 2016 Dec 1.
7
Thymosin β4 Promotes Dermal Healing.胸腺素β4促进皮肤愈合。
Vitam Horm. 2016;102:251-75. doi: 10.1016/bs.vh.2016.04.005. Epub 2016 May 24.
8
Ocular surface mucins and local inflammation--studies in genetically modified mouse lines.眼表黏蛋白与局部炎症——转基因小鼠品系研究
BMC Ophthalmol. 2015 Dec 17;15 Suppl 1(Suppl 1):154. doi: 10.1186/s12886-015-0137-5.
9
Effects of chondrocyte-derived extracellular matrix in a dry eye mouse model.软骨细胞衍生的细胞外基质在干眼小鼠模型中的作用。
Mol Vis. 2015 Oct 26;21:1210-23. eCollection 2015.
10
Thymosin beta 4 up-regulates miR-200a expression and induces differentiation and survival of rat brain progenitor cells.胸腺素β4上调miR-200a的表达并诱导大鼠脑祖细胞的分化和存活。
J Neurochem. 2016 Jan;136(1):118-32. doi: 10.1111/jnc.13394. Epub 2015 Nov 10.